- Transcenta to Present "Trial in Progress" at ASCO-GI 2023 for TST001 (Osemitamab) Combination with Nivolumab, with or without Chemotherapy in Advanced G/GEJ Cancer
- Transcenta Received IND Clearance from NMPA for Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors
- Transcenta Presented Two Scientific Posters at SITC 2022 Annual Meeting
- Transcenta to Hold 3 Exchange Sessions on Post-SITC Business Update Call & TST003 data release and pipeline development progress update
Key statistics
On Friday, Transcenta Holding Limited (6628:HKG) closed at 3.03, 42.92% above the 52 week low of 2.12 set on Aug 24, 2022.
52-week range
Open | 3.02 |
---|---|
High | 3.18 |
Low | 3.01 |
Bid | 3.03 |
Offer | 3.05 |
Previous close | 3.02 |
Average volume | 113.72k |
---|---|
Shares outstanding | 419.92m |
Free float | 303.02m |
P/E (TTM) | -- |
Market cap | 1.27bn HKD |
EPS (TTM) | -2.41 HKD |
Data delayed at least 15 minutes, as of Jan 27 2023 08:08 GMT.
More ▼